Product Images Atorvastatin Calcium

This is a description of Atorvastatin Calcium Tablets, a medication that comes in a bottle with 90 tablets. This medication is only available with a valid prescription from a healthcare provider. It is indicated to lower "bad" cholesterol (LDL), increase "good" cholesterol (HDL), and lower triglycerides in the blood. The usual dose must be obtained from the package insert or from the prescribing physician. The tablets must be stored at temperatures between 20°C and 25°C. The manufacturer is SN Laboratories Private Limited in India, and the distributor is Novadoz Pharmaceuticals LLC, located in New Jersey. The medication is identifiable by the GTIN and lot number. There is a coding area on the pack that is 40 x 28 mm.*

This appears to be an output of a medicine label that includes details like product name, dosage, storage instructions, manufacturer information, and other relevant details. It is mentioned that the usual dosage information is given in the package insert. The medicine is Atorvastatin and the package contains 1000 tablets. The label mentions that it was issued in June 2021 by MDL Ltd. The text also includes some alphanumeric codes, product identifiers, and symbols.*

This is a description of a medication for which the package insert should be consulted for complete prescription information. The medication contains Atorvastatin Calcium equivalent to 20 mg of atorvastatin, and comes in a bottle of 500 tablets. It was manufactured in India and is distributed by Novadoz Pharmaceuticals LLC in New Jersey. The medication should be stored at normal room temperature, and its packaging features lot and variant information.*

Atorvastatin Calcium Tablets USP are prescription medication used to treat high cholesterol levels and reduce the risk of heart attack or stroke. This particular version contains 90 tablets, each of which is film-coated and contains 20mg of atorvastatin calcium, with usual dosage information provided in the package insert. The tablets should be stored between 20-25°C (66-77°F). Manufactured by MSN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals LLC in New Jersey, this medication is marked as Rx-only and includes specific coding requirements for packaging. Additional details such as GTIN, SN, EXP, and LOT numbers are provided for tracking purposes.*

The text is a description of a medication, specifically Atorvastatin Calcium Tablets USP, distributed by Novadoz Pharmaceuticals LLC. It contains information about the dosage, ingredients, and storage directions. The usual dosage guidelines are not provided, but they can be found in the package insert. The medication is manufactured by MSN Laboratories Private Limited in Telangana, India. The text also includes a code, an expiration date, and a reference to a coding area.*

This is a description of a medication called Atorvastatin Calcium. It comes in the form of 500 tablets, each of which is film-coated and contains 40mg of Atorvastatin calcium. The medication is only available via a prescription and the recommended dosage should be determined by the prescribing physician. The medication should be stored between 20 to 25 degrees Celsius. The manufacturer is SN Laboratories Private Limited in India, and it is distributed by Novadoz Pharmaceuticals in Piscataway, New Jersey. The text also includes various product codes and identifiers.*

This is a description of Atorvastatin Calcium Tablets USP sold by Novadoz Pharmaceuticals in a package containing 90 tablets. Each film-coated tablet contains 40mg of atorvastatin calcium. The package insert should be consulted for full prescribing information. It is only available with a prescription. The tablets are manufactured by MSN Laboratories in Telangana, India and distributed by Novadoz Pharmaceuticals in Piscataway, New Jersey. The tablets should be stored at controlled room temperature of 20 to 25°C (68 to 77°F). The product has a GTIN number, EXP date, LOT number, and coding area for over coding during packing.*

This is a description of a medication package containing Atorvastatin Calcium tablets USP. The package has 1000 film-coated tablets with each tablet containing atorvastatin calcium equivalent to atorvastatin 80mg. The usual dosage is provided in the package insert, and the medication should be stored at 20°C to 25°C. The manufacturer is MSN Laboratories Private Limited, and the medication is distributed by Novadoz Pharmaceuticals LLC. The package has a coding area of 42x35mm.*

This is medication information for Atorvastatin Calcium Tablets USP, manufactured by MSN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals LLC in the United States. Each film-coated tablet contains atorvastatin calcium equivalent to 80 mg of atorvastatin, and the normal dosage information can be found in the accompanying package insert. The tablets are stored between 20 and 25°C according to the USP Controlled Room Temperature guidelines. The text also includes information on issuing date, lot number, and a coding area for tracking and inventory purposes.*

This is a description of a medication called Atorvastatin Calcium. It comes in a bottle with 90 film-coated tablets, each containing 80 mg of Atorvastatin Calcium. The usual dosage is described in the package insert, and it should be stored at room temperature. The tablets are manufactured by a company called Tablets USP 11awesssiiisim and distributed by Novadoz Pharmaceuticals LLC. It is available only with a prescription. There are also some codes and details provided about the product's packaging.*

The text provides a cumulative hazard percentage of 1517 along with some numerical values and a graph showing the time to the first primary endpoint through four years of follow-up. Additionally, there is a hazard ratio of 0.63 with a statistically significant p-value. It appears to be a medical or epidemiological study.*

The text describes a table with the percentage of subjects experiencing an event. The table shows the results for Atorvastatin 10mg and 80mg, with a comparison between them using HR (Hazard Ratio) values. The table also shows the time in years for the first major cardiovascular endpoint. No information is available about what the event or subjects are.*